Literature DB >> 16542786

Rapid recovery from major depression using magnesium treatment.

George A Eby1, Karen L Eby.   

Abstract

Major depression is a mood disorder characterized by a sense of inadequacy, despondency, decreased activity, pessimism, anhedonia and sadness where these symptoms severely disrupt and adversely affect the person's life, sometimes to such an extent that suicide is attempted or results. Antidepressant drugs are not always effective and some have been accused of causing an increased number of suicides particularly in young people. Magnesium deficiency is well known to produce neuropathologies. Only 16% of the magnesium found in whole wheat remains in refined flour, and magnesium has been removed from most drinking water supplies, setting a stage for human magnesium deficiency. Magnesium ions regulate calcium ion flow in neuronal calcium channels, helping to regulate neuronal nitric oxide production. In magnesium deficiency, neuronal requirements for magnesium may not be met, causing neuronal damage which could manifest as depression. Magnesium treatment is hypothesized to be effective in treating major depression resulting from intraneuronal magnesium deficits. These magnesium ion neuronal deficits may be induced by stress hormones, excessive dietary calcium as well as dietary deficiencies of magnesium. Case histories are presented showing rapid recovery (less than 7 days) from major depression using 125-300 mg of magnesium (as glycinate and taurinate) with each meal and at bedtime. Magnesium was found usually effective for treatment of depression in general use. Related and accompanying mental illnesses in these case histories including traumatic brain injury, headache, suicidal ideation, anxiety, irritability, insomnia, postpartum depression, cocaine, alcohol and tobacco abuse, hypersensitivity to calcium, short-term memory loss and IQ loss were also benefited. Dietary deficiencies of magnesium, coupled with excess calcium and stress may cause many cases of other related symptoms including agitation, anxiety, irritability, confusion, asthenia, sleeplessness, headache, delirium, hallucinations and hyperexcitability, with each of these having been previously documented. The possibility that magnesium deficiency is the cause of most major depression and related mental health problems including IQ loss and addiction is enormously important to public health and is recommended for immediate further study. Fortifying refined grain and drinking water with biologically available magnesium to pre-twentieth century levels is recommended.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542786     DOI: 10.1016/j.mehy.2006.01.047

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  58 in total

Review 1.  The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.

Authors:  Jing Du; Ming Zhu; Hongkun Bao; Bai Li; Yilong Dong; Chunjie Xiao; Grace Y Zhang; Ioline Henter; Matthew Rudorfer; Benedetto Vitiello
Journal:  Crit Rev Food Sci Nutr       Date:  2016-11-17       Impact factor: 11.176

2.  Role of Cellular Magnesium in Human Diseases.

Authors:  Samantha Long; Andrea Mp Romani
Journal:  Austin J Nutr Food Sci       Date:  2014-11-18

Review 3.  Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.

Authors:  Sunil Goodwani; Hannah Saternos; Fawaz Alasmari; Youssef Sari
Journal:  Neurosci Biobehav Rev       Date:  2017-02-24       Impact factor: 8.989

4.  Prevalence of depression, fatigue, and sleep disturbances in patients with myelopathy: Their relation with functional and neurological recovery.

Authors:  Nitin Menon; Anupam Gupta; Meeka Khanna; Arun B Taly; K Thennarasu
Journal:  J Spinal Cord Med       Date:  2016-02-15       Impact factor: 1.985

5.  Angiotensin-Converting Enzyme Inhibitor Use and Incident Frailty: A Longitudinal Cohort Study.

Authors:  Nicola Veronese; Brendon Stubbs; Lee Smith; Stefania Maggi; Sarah E Jackson; Pinar Soysal; Jacopo Demurtas; Stefano Celotto; Ai Koyanagi
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

6.  Prospective associations of cardiovascular disease with physical performance and disability : A longitudinal cohort study in the Osteoarthritis Initiative.

Authors:  Nicola Veronese; Brendon Stubbs; Sarah E Jackson; Ai Koyanagi; Vania Noventa; Francesco Bolzetta; Alberto Cester; Pinar Soysal; Stefania Maggi; Guillermo F López-Sánchez; Mike Loosemore; Jacopo Demurtas; Lee Smith
Journal:  Wien Klin Wochenschr       Date:  2019-11-05       Impact factor: 1.704

7.  Mediterranean diet and knee osteoarthritis outcomes: A longitudinal cohort study.

Authors:  Nicola Veronese; Ai Koyanagi; Brendon Stubbs; Cyrus Cooper; Giuseppe Guglielmi; Renè Rizzoli; Leonardo Punzi; Domenico Rogoli; Maria Gabriella Caruso; Ornella Rotolo; Maria Notarnicola; Nasser Al-Daghri; Lee Smith; Jean-Yves Reginster; Stefania Maggi
Journal:  Clin Nutr       Date:  2018-12-04       Impact factor: 7.324

8.  Micronutrient intake adequacy and depression risk in the SUN cohort study.

Authors:  Almudena Sánchez-Villegas; Aurora Pérez-Cornago; Itziar Zazpe; Susana Santiago; Francisca Lahortiga; Miguel Angel Martínez-González
Journal:  Eur J Nutr       Date:  2017-09-04       Impact factor: 5.614

9.  Statin Use and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study.

Authors:  Nicola Veronese; Ai Koyanagi; Brendon Stubbs; Cyrus Cooper; Giuseppe Guglielmi; Renè Rizzoli; Patricia Schofield; Leonardo Punzi; Nasser Al-Daghri; Lee Smith; Stefania Maggi; Jean-Yves Reginster
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-08       Impact factor: 4.794

10.  Understanding nutrition, depression and mental illnesses.

Authors:  T S Sathyanarayana Rao; M R Asha; B N Ramesh; K S Jagannatha Rao
Journal:  Indian J Psychiatry       Date:  2008-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.